Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
€262.90
Available for sending in 4/5 days
Product Information
| ISBN | 9781461288886 |
|---|---|
| Publisher | Springer-Verlag New York Inc. |
| Price (excl. tax) | €248.02 |
| Tax | €14.88 |
| Price (incl. tax) | €262.90 |
| Availability | 1 unit in external warehouse |
Product Description
The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.